Tanshinone-1 induces tumor cell killing, enhanced by inhibition of secondary activation of signaling networks
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tanshinone-1 induces tumor cell killing, enhanced by inhibition of secondary activation of signaling networks
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 4, Issue 11, Pages e905-e905
Publisher
Springer Nature
Online
2013-11-07
DOI
10.1038/cddis.2013.443
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tanshinone IIA protects rabbits against LPS-induced disseminated intravascular coagulation (DIC)
- (2012) Liang-cai Wu et al. ACTA PHARMACOLOGICA SINICA
- Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II
- (2012) S. G. Manzo et al. CANCER RESEARCH
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Collateral sensitivity as a strategy against cancer multidrug resistance
- (2012) Kristen M. Pluchino et al. DRUG RESISTANCE UPDATES
- Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies
- (2012) Laleh Amiri-Kordestani et al. DRUG RESISTANCE UPDATES
- Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1
- (2012) Jean-Pierre Gillet et al. DRUG RESISTANCE UPDATES
- Modular pharmacology: the next paradigm in drug discovery
- (2012) Zhong Wang et al. Expert Opinion on Drug Discovery
- Pseudolaric acid B-driven phosphorylation of c-Jun impairs its role in stabilizing HIF-1alpha: a novel function-converter model
- (2012) Bing Yu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Bioactive tanshinone I inhibits the growth of lung cancer in part via downregulation of Aurora A function
- (2012) Yanli Li et al. MOLECULAR CARCINOGENESIS
- First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
- (2012) Malabika Sen et al. Cancer Discovery
- Depletion of insulin receptor substrate 2 reverses oncogenic transformation induced by v-src
- (2011) Hong-zhi Sun et al. ACTA PHARMACOLOGICA SINICA
- HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition
- (2011) Karuppaiyah Selvendiran et al. CANCER BIOLOGY & THERAPY
- Combined Blockade of Src Kinase and Epidermal Growth Factor Receptor with Gemcitabine Overcomes STAT3-Mediated Resistance of Inhibition of Pancreatic Tumor Growth
- (2011) N. S. Nagaraj et al. CLINICAL CANCER RESEARCH
- Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?
- (2011) Anna Brózik et al. Expert Opinion on Drug Metabolism & Toxicology
- Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice
- (2011) Grace-Ifeyinwa Onimoe et al. INVESTIGATIONAL NEW DRUGS
- Drug Transporter-independent Liver Cancer Cell Killing by a Marine Steroid Methyl Spongoate via Apoptosis Induction
- (2011) Yi Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1
- (2011) Peramaiyan Rajendran et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
- (2011) Chung-Pu Wu et al. MOLECULAR PHARMACEUTICS
- Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents
- (2011) Yizhou Dong et al. NATURAL PRODUCT REPORTS
- Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
- (2011) Alfonso Quintás-Cardama et al. NATURE REVIEWS DRUG DISCOVERY
- Multiple signal pathways in obesity-associated cancer
- (2011) J. Chen Obesity Reviews
- Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion
- (2011) H Feng et al. ONCOGENE
- Tanshinone I increases CYP1A2 protein expression and enzyme activity in primary rat hepatocytes
- (2011) Wayne Y.W. Lee et al. PHYTOMEDICINE
- Deactivation of Signal Transducer and Activator of Transcription 3 Reverses Chemotherapeutics Resistance of Leukemia Cells via Down-Regulating P-gp
- (2011) Xulong Zhang et al. PLoS One
- Akt Regulates IL-10 Mediated Suppression of TNFα-Induced Cardiomyocyte Apoptosis by Upregulating Stat3 Phosphorylation
- (2011) Sanjiv Dhingra et al. PLoS One
- Mechanisms and functions of p38 MAPK signalling
- (2010) Ana Cuadrado et al. BIOCHEMICAL JOURNAL
- STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma
- (2010) A Horiguchi et al. BRITISH JOURNAL OF CANCER
- BB, a new EGFR inhibitor, exhibits prominent anti-angiogenesis and antitumor activities
- (2010) Qi-Ming Sun et al. CANCER BIOLOGY & THERAPY
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
- (2009) Heehyoung Lee et al. CANCER CELL
- Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2
- (2009) Boris R. A. Blechacz et al. HEPATOLOGY
- Disposition and toxicity of trabectedin (ET-743) in wild-type and mdr1 gene (P-gp) knock-out mice
- (2009) J. H. Beumer et al. INVESTIGATIONAL NEW DRUGS
- Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules
- (2008) I. T. Nizamutdinova et al. CARCINOGENESIS
- JAK/STAT and PI3K/AKT Pathways Form a Mutual Transactivation Loop and Afford Resistance to Oxidative Stress-Induced Apoptosis in Cardiomyocytes
- (2008) Yanjie Lu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Anticancer effects of tanshinone I in human non-small cell lung cancer
- (2008) C.-Y. Lee et al. MOLECULAR CANCER THERAPEUTICS
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
- Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFκB pathway
- (2007) Byeong Hyeok Choi et al. CANCER LETTERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started